Clinical Trial Update: Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating combination chemotherapy for transitional cell cancers of the urothelium has completed, including bladder cancer and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Renal Pelvis and Ureter
• Urethral Cancer

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2, Phase 3 | Status: COMPLETED